Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " January 11, 2008":" February 08, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
Condition: HIV Infections
Interventions: Drug: Dapivirine Gel 4750, 0.05%, 2.5g;   Drug: Dapivirine Gel 4789, 0.05%, 2.5g;   Drug: HEC-based Placebo Gel
2 Completed Naïve HIV POC Monotherapy Trial
Condition: HIV Infections
Interventions: Drug: RDEA806 400 mg;   Drug: Placebo;   Drug: RDEA806 1000 mg;   Drug: RDEA806 600 mg;   Drug: RDEA806 800 mg
3 Completed Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)
Condition: HIV Infections
Intervention: Drug: Vicriviroc
4 Completed ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla
Condition: HIV Infections
Intervention: Drug: Atripla (ATR) consisting of EFV 600 mg/FTC 200 mg/TDF 300 mg
5 Completed Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
Condition: HIV Infections
Interventions: Behavioral: HIV-related text messaging;   Behavioral: Nutrition-related text messaging
6 Completed
Has Results
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate;   Drug: Zidovudine;   Drug: Emtricitabine
7 Completed HIV, Abuse, and Psychiatric Disorders Among Youth
Condition: HIV Infections
Intervention: Behavioral: group intervention
8 Completed Mindfulness Meditation Training in HIV
Condition: HIV Infections
Intervention: Behavioral: MBSR
9 Completed Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: Lamivudine (3TC)
10 Completed Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
Condition: HIV Infections
Interventions: Drug: Lumefantrine - lopinavir/ritonavir drug interaction;   Drug: Lumefantrine only arm
11 Completed ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
Interventions: Drug: Atripla;   Drug: Kivexa plus Sustiva
12 Completed Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort
Condition: HIV Infections
Interventions: Drug: Zidovudine (AZT)+ Didanosine (ddI)+ Nevirapine (NVP);   Drug: Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP);   Drug: Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP)
13 Completed Cognitive Stimulation Program in AIDS
Condition: HIV Infections
Intervention: Behavioral: Smartbrain
14 Completed
Has Results
PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: PRO 140;   Drug: Placebo
15 Completed Pharmacokinetic Study on Raltegravir and Lamotrigine
Condition: HIV Infection
Interventions: Drug: lamotrigine;   Drug: Raltegravir
16 Completed Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
Condition: HIV Infections
Intervention: Behavioral: NO BI Drug administered
17 Completed
Has Results
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
18 Completed INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized background ARV therapy
19 Completed Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
Condition: HIV Infections
Intervention: Drug: TPV
20 Completed Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
Condition: HIV Infections
Interventions: Drug: Darunavir 900mg + ritonavir 100 mg once a day;   Drug: Darunavir 600mg + ritonavir 100mg twice day

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.